ATHE — Alterity Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $30.85m
- $27.99m
- AU$0.27m
- 29
- 2
- 100
- 39
Annual balance sheet for Alterity Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9.2 | 28.1 | 34.8 | 15.8 | 12.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.061 | 4.28 | 4.73 | 8.67 | 4.04 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9.84 | 33.5 | 41.1 | 27 | 19 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.071 | 0.097 | 0.219 | 0.269 | 0.187 |
| Total Assets | 9.91 | 33.6 | 41.4 | 27.3 | 19.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.71 | 3.07 | 5.82 | 4.38 | 5.37 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.76 | 3.12 | 5.89 | 4.5 | 5.43 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 7.15 | 30.5 | 35.5 | 22.8 | 13.8 |
| Total Liabilities & Shareholders' Equity | 9.91 | 33.6 | 41.4 | 27.3 | 19.2 |
| Total Common Shares Outstanding |